Showing 1–6 of 6 results for author: Mahajan, A

Analysis of the MICCAI Brain Tumor Segmentation -- Metastases (BraTS-METS) 2025 Lighthouse Challenge: Brain Metastasis Segmentation on Pre- and Post-treatment MRI

Authors: Nazanin Maleki, Raisa Amiruddin, Ahmed W. Moawad, Nikolay Yordanov, Athanasios Gkampenis, Pascal Fehringer, Fabian Umeh, Crystal Chukwurah, Fatima Memon, Bojan Petrovic, Justin Cramer, Mark Krycia, Elizabeth B. Shrickel, Ichiro Ikuta, Gerard Thompson, Lorenna Vidal, Vilma Kosovic, Adam E. Goldman-Yassen, Virginia Hill, Tiffany So, Sedra Mhana, Albara Alotaibi, Nathan Page, Prisha Bhatia, Yasaman Sharifi , et al. (218 additional authors not shown)

Abstract: Despite continuous advancements in cancer treatment, brain metastatic disease remains a significant complication of primary cancer and is associated with an unfavorable prognosis. One approach for improving diagnosis, management, and outcomes is to implement algorithms based on artificial intelligence for the automated segmentation of both pre- and post-treatment MRI brain images. Such algorithms… ▽ More Despite continuous advancements in cancer treatment, brain metastatic disease remains a significant complication of primary cancer and is associated with an unfavorable prognosis. One approach for improving diagnosis, management, and outcomes is to implement algorithms based on artificial intelligence for the automated segmentation of both pre- and post-treatment MRI brain images. Such algorithms rely on volumetric criteria for lesion identification and treatment response assessment, which are still not available in clinical practice. Therefore, it is critical to establish tools for rapid volumetric segmentations methods that can be translated to clinical practice and that are trained on high quality annotated data. The BraTS-METS 2025 Lighthouse Challenge aims to address this critical need by establishing inter-rater and intra-rater variability in dataset annotation by generating high quality annotated datasets from four individual instances of segmentation by neuroradiologists while being recorded on video (two instances doing "from scratch" and two instances after AI pre-segmentation). This high-quality annotated dataset will be used for testing phase in 2025 Lighthouse challenge and will be publicly released at the completion of the challenge. The 2025 Lighthouse challenge will also release the 2023 and 2024 segmented datasets that were annotated using an established pipeline of pre-segmentation, student annotation, two neuroradiologists checking, and one neuroradiologist finalizing the process. It builds upon its previous edition by including post-treatment cases in the dataset. Using these high-quality annotated datasets, the 2025 Lighthouse challenge plans to test benchmark algorithms for automated segmentation of pre-and post-treatment brain metastases (BM), trained on diverse and multi-institutional datasets of MRI images obtained from patients with brain metastases. △ Less

Submitted 6 May, 2025; v1 submitted 16 April, 2025; originally announced April 2025.

Comments: 28 pages, 4 figures, 2 tables

Multiscale Modeling Primer: Focus on Chromatin and Epigenetics

Authors: Achal Mahajan, Erik J. Navarro, William Poole, Carlos F Lopez

Abstract: Essential life processes take place across multiple space and time scales in living organisms but understanding their mechanistic interactions remains an ongoing challenge. Advanced multiscale modeling techniques are providing new opportunities and insights into these complex processes. In cells, meters of chromatin are folded into a nucleus with a diameter on the order of microns. The three-dimen… ▽ More Essential life processes take place across multiple space and time scales in living organisms but understanding their mechanistic interactions remains an ongoing challenge. Advanced multiscale modeling techniques are providing new opportunities and insights into these complex processes. In cells, meters of chromatin are folded into a nucleus with a diameter on the order of microns. The three-dimensional chromatin structure coupled with biochemical processes that turn genes on or off, specify a given cell type through a complicated set of interactions collectively referred to as epigenetics. Important epigenetic processes include the differential accessibility of genomic loci to transcription factors and chemical modifications to DNA and DNA-binding molecules such as histones. The dynamics of these epigenetic processes span timescales from milliseconds to years. How do chemical modifications consisting of a handful of atoms cooperate to modulate genome folding at the scale of the nucleus and impact organism outcomes? In this review, we highlight the inherently multiscale nature of chromatin organization, with a focus on computational modeling to bridge the gaps in our understanding of biochemical processes across scales. We review relevant chromatin biology, including major types of epigenetic modifications as well as the higher order chromatin structures to present a multiscale view of chromatin. We also review relevant computational methods to simulate chromatin structure, function, and dynamics, as well as experimental techniques that inform and validate said models. Finally, we argue that multiscale modeling provides a path forward towards understanding emergent behavior in this inherently multiscale system. △ Less

Submitted 4 April, 2025; originally announced April 2025.

BioNeMo Framework: a modular, high-performance library for AI model development in drug discovery

Authors: Peter St. John, Dejun Lin, Polina Binder, Malcolm Greaves, Vega Shah, John St. John, Adrian Lange, Patrick Hsu, Rajesh Illango, Arvind Ramanathan, Anima Anandkumar, David H Brookes, Akosua Busia, Abhishaike Mahajan, Stephen Malina, Neha Prasad, Sam Sinai, Lindsay Edwards, Thomas Gaudelet, Cristian Regep, Martin Steinegger, Burkhard Rost, Alexander Brace, Kyle Hippe, Luca Naef , et al. (63 additional authors not shown)

Abstract: Artificial Intelligence models encoding biology and chemistry are opening new routes to high-throughput and high-quality in-silico drug development. However, their training increasingly relies on computational scale, with recent protein language models (pLM) training on hundreds of graphical processing units (GPUs). We introduce the BioNeMo Framework to facilitate the training of computational bio… ▽ More Artificial Intelligence models encoding biology and chemistry are opening new routes to high-throughput and high-quality in-silico drug development. However, their training increasingly relies on computational scale, with recent protein language models (pLM) training on hundreds of graphical processing units (GPUs). We introduce the BioNeMo Framework to facilitate the training of computational biology and chemistry AI models across hundreds of GPUs. Its modular design allows the integration of individual components, such as data loaders, into existing workflows and is open to community contributions. We detail technical features of the BioNeMo Framework through use cases such as pLM pre-training and fine-tuning. On 256 NVIDIA A100s, BioNeMo Framework trains a three billion parameter BERT-based pLM on over one trillion tokens in 4.2 days. The BioNeMo Framework is open-source and free for everyone to use. △ Less

Submitted 15 November, 2024; originally announced November 2024.

The Brain Tumor Segmentation (BraTS-METS) Challenge 2023: Brain Metastasis Segmentation on Pre-treatment MRI

Authors: Ahmed W. Moawad, Anastasia Janas, Ujjwal Baid, Divya Ramakrishnan, Rachit Saluja, Nader Ashraf, Nazanin Maleki, Leon Jekel, Nikolay Yordanov, Pascal Fehringer, Athanasios Gkampenis, Raisa Amiruddin, Amirreza Manteghinejad, Maruf Adewole, Jake Albrecht, Udunna Anazodo, Sanjay Aneja, Syed Muhammad Anwar, Timothy Bergquist, Veronica Chiang, Verena Chung, Gian Marco Conte, Farouk Dako, James Eddy, Ivan Ezhov , et al. (207 additional authors not shown)

Abstract: The translation of AI-generated brain metastases (BM) segmentation into clinical practice relies heavily on diverse, high-quality annotated medical imaging datasets. The BraTS-METS 2023 challenge has gained momentum for testing and benchmarking algorithms using rigorously annotated internationally compiled real-world datasets. This study presents the results of the segmentation challenge and chara… ▽ More The translation of AI-generated brain metastases (BM) segmentation into clinical practice relies heavily on diverse, high-quality annotated medical imaging datasets. The BraTS-METS 2023 challenge has gained momentum for testing and benchmarking algorithms using rigorously annotated internationally compiled real-world datasets. This study presents the results of the segmentation challenge and characterizes the challenging cases that impacted the performance of the winning algorithms. Untreated brain metastases on standard anatomic MRI sequences (T1, T2, FLAIR, T1PG) from eight contributed international datasets were annotated in stepwise method: published UNET algorithms, student, neuroradiologist, final approver neuroradiologist. Segmentations were ranked based on lesion-wise Dice and Hausdorff distance (HD95) scores. False positives (FP) and false negatives (FN) were rigorously penalized, receiving a score of 0 for Dice and a fixed penalty of 374 for HD95. Eight datasets comprising 1303 studies were annotated, with 402 studies (3076 lesions) released on Synapse as publicly available datasets to challenge competitors. Additionally, 31 studies (139 lesions) were held out for validation, and 59 studies (218 lesions) were used for testing. Segmentation accuracy was measured as rank across subjects, with the winning team achieving a LesionWise mean score of 7.9. Common errors among the leading teams included false negatives for small lesions and misregistration of masks in space.The BraTS-METS 2023 challenge successfully curated well-annotated, diverse datasets and identified common errors, facilitating the translation of BM segmentation across varied clinical environments and providing personalized volumetric reports to patients undergoing BM treatment. △ Less

Submitted 8 December, 2024; v1 submitted 1 June, 2023; originally announced June 2023.

Utilization of 3D segmentation for measurement of pediatric brain tumor outcomes after treatment: review of available free tools, step-by-step instructions, and applications to clinical practice

Authors: Marina Kazarian, Sandra Abi Fadel, Amit Mahajan, Mariam Aboian

Abstract: Volumetric measurements are known to provide more information when it comes to segmenting tumors, in comparison to one- and two-dimensional measurements, and thus can lead to better informed therapy. In this work, we review the free and easily accessible computer platforms available for conducting these 3D measurements, such as Horos and 3D Slicer and compare the segmentations to commercial Visage… ▽ More Volumetric measurements are known to provide more information when it comes to segmenting tumors, in comparison to one- and two-dimensional measurements, and thus can lead to better informed therapy. In this work, we review the free and easily accessible computer platforms available for conducting these 3D measurements, such as Horos and 3D Slicer and compare the segmentations to commercial Visage software. We compare the time for 3D segmentation of tumors and demonstrate how to use a novel plugin that we developed in 3D slicer for the efficient and accurate segmentation of the cystic component of a tumor. △ Less

Submitted 30 August, 2020; originally announced August 2020.

An Epidemic Model SIPHERD and its application for prediction of the spread of COVID-19 infection for India and USA

Authors: Ashutosh Mahajan, Ravi Solanki, A. S. Namitha

Abstract: We propose an epidemic model SIPHERD in which three categories of infection carriers Symptomatic, Purely Asymptomatic, and Exposed are considered with different rates of transmission of infection that are taken dependent on the lockdown and social distancing. The rate of detection of the infected carriers is taken dependent on the tests done per day. The model is applied for the COVID outbreak in… ▽ More We propose an epidemic model SIPHERD in which three categories of infection carriers Symptomatic, Purely Asymptomatic, and Exposed are considered with different rates of transmission of infection that are taken dependent on the lockdown and social distancing. The rate of detection of the infected carriers is taken dependent on the tests done per day. The model is applied for the COVID outbreak in Germany and South Korea to validate its predictive capabilities and then applied to India and the United States for the prediction of its spread with different lockdown situations and testing in the coming months. △ Less

Submitted 11 May, 2020; v1 submitted 2 May, 2020; originally announced May 2020.

Comments: 6 pages, 11 figures